menu
    • menu

    Company profile for Versantis

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, is currently at clinical stage (Phase Ib) and has the potential to be the first drug for ac...
    Versantis is a Swiss pharmaceutical company, Spin-off of ETH Zurich, developing a new generation of medicines and diagnostics to revolutionize the care of patients with liver disease. Embracing lifesaving and preventive therapies, Versantis aims to answer the unmet medical need of millions of people worldwide. Its lead candidate, VS-01, is currently at clinical stage (Phase Ib) and has the potential to be the first drug for acute liver disease simultaneously supporting multiple failing organs. VS-01 targets 3 rare indications and received an Orphan Drug Designation in ALF.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VersantisSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Technoparkstrasse 1 3rd floor, Newton wing 3007 CH-8005 Zurich
    Telephone
    Telephone
    +41445008891
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.versantis.ch/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/versantis
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/VersantisAG

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    GENFIT Announces Signature of the Share Purchase Agreement tis
    GENFIT Announces Signature of the Share Purchase Agreement tis

    29 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/29/2525625/0/en/GENFIT-Announces-Signature-of-the-Share-Purchase-Agreement-and-the-Completion-of-its-Acquisition-of-Versantis.html

    GLOBENEWSWIRE
    29 Sep 2022
    Share Share
    Versant Ventures Launches Vector BioPharma AG
    Versant Ventures Launches Vector BioPharma AG

    10 Aug 2022

    // WALDERWYSS

    https://www.walderwyss.com/fr/news/2022-08-12_versant-ventures-launches-vector-biopharma-with-usd-30m-series-a#:~:text=Versant%20Ventures%20launches%20Vector%20BioPharma%20with%20USD%2030m%20Series%20A,is%20devoid%20of%20viral%20genes.

    WALDERWYSS
    10 Aug 2022
    Share Share
    Versantis Presents New VS-01 Data at The International Liver CongressTM 2022
    Versantis Presents New VS-01 Data at The International Liver CongressTM 2022

    24 Jun 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220624005132/en

    BUSINESSWIRE
    24 Jun 2022
    Share Share
    Versantis to Present Positive Phase 1b Data at AASLD for VS-01
    Versantis to Present Positive Phase 1b Data at AASLD for VS-01

    15 Nov 2021

    // BIOSPACE

    https://www.biospace.com/article/releases/versantis-to-present-positive-phase-1b-data-at-aasld-for-vs-01-in-patients-with-decompensated-cirrhosis/?s=114

    BIOSPACE
    15 Nov 2021
    Share Share
    Versantis Appoints Prof Dr Katharina Staufer as Chief Medical Officer
    Versantis Appoints Prof Dr Katharina Staufer as Chief Medical Officer

    19 Oct 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211019005130/en

    BUSINESSWIRE
    19 Oct 2021
    Share Share
    Versantis Receives U.S. FDA Orphan Drug Designation for VS-01
    Versantis Receives U.S. FDA Orphan Drug Designation for VS-01

    07 Sep 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20210907005194/en/Versantis-Receives-U.S.-FDA-Orphan-Drug-Designation-for-VS-01

    BUSINESSWIRE
    07 Sep 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search